Advertisement

Topics

Minomic Launches US Prospective Study of MiCheck® Prostate Cancer Test

11:00 EDT 17 Jul 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Novel prostate cancer screening technology targeting commercialization in 2017 Verification of test accuracy and reliability for CLIA lab access Minomic International Ltd, an Australian immuno-oncology company, has ...

Other Sources for this Article

Minomic International Ltd
Brad Walsh, Ph.D., +61 413-231-296
Chief Executive Officer

NEXT ARTICLE

More From BioPortfolio on "Minomic Launches US Prospective Study of MiCheck® Prostate Cancer Test"

Quick Search
Advertisement
 

Relevant Topics

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...